Bessemer Venture Partners

Bessemer Venture Partners is a $4 billion venture capital firm founded in 1911 and based in California, specializing in investments across consumer, enterprise, and healthcare sectors globally, from seed stage to growth. The firm supports founders by providing guidance and resources, starting with seed and Series A investments and maintaining involvement throughout the development of their companies. Bessemer has a diverse portfolio, having funded early-stage companies such as Pinterest, Blue Apron, Skype, and Twitch, and has played a role in the successful initial public offerings of 117 companies, including Twilio, Yelp, and LinkedIn. The firm also operates several specialized funds targeting various sectors, including information technology, software, and digital health, with a presence in key markets such as India and Israel.

Rob Arditi

Partner

Anurag Begwani

Investor

Kent Bennett

Partner

Mark S. Bercow

Operating Partner

Charles Birnbaum

Partner

Sam Bondy

Investor

Robert H. Buescher

Administrative Partner

Sara Byrne

Director, GP Accounting

Aparna Chaganty

Investor

Morgan Cheatham

vice_president

Chris Chesney

Associate

J. Edmund Colloton

Managing Partner and COO

Ed Colloton

Partner

David Cowan

Partner

Mary D'Onofrio

Partner

Byron Deeter

Partner

Sameer Dholakia

Partner

John Drake

Investor

Mike Droesch

Partner

David Erickson

Operating Partner

Alex Ferrara

Partner

Adam Fisher

Partner

Christopher Gabrieli

Partner

Talia Goldberg

Partner

Bob Goodman

Partner

Robert P. Goodman

Partner

Sandy Grippo

Chief Financial Officer and Partner

Sofia Guerra

Investor

Vishal Gupta

Partner

Felda Hardymon

Partner

Tess Hatch

Partner

Andrew Hedin

Partner

Eric Kaplan

Investor

Amit Karp

Partner

Stephen Kraus

Partner

Ethan Kurzweil

Partner

Waikit Lau

Associate

Jeremy Levine

Partner

Lindsey Li

Investor

Emily Lu

Venture Capitalist

Grace Ma

Investor

Bennett Mathews

Senior Associate

Bhavik Nagda

Investor

Aditya Nidmarti

Investor

Robert O'Neil

Partner

Darsh Patel

Investor

Anant Vidur Puri

Partner

Anant Vidur Puri

Partner

Dan Ramirez

Associate

Caty Rea

vice_president

Elliott Robinson

Partner & Co-Founder of the Growth Investment Practice

Aia Sarycheva

Investor

Yael Schiff

Investor

Madeline Shue

Investor

Rob Stavis

Partner

Ariel Sterman

vice_president

Nancy Straface

Vice president of investment accounting

Mayo Stuntz

Operating Partner

Alexandra Sukin

Investor

Janelle Teng

vice_president

Christopher Wan

Investor

Connor Watumull

Senior Associate

David Wehrs

Partner

Augie Wilkinson

Director, Portfolio Monitoring and Analysis

Alex Yuditski

Investor

Past deals in New England

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Courier

Series B in 2022
Courier provides an API designed for developers to enhance user notification delivery by intelligently routing messages across various existing channels, such as email and messaging platforms. The API takes into account factors like user online status and previous engagement levels to determine the most effective communication method. Over the years, Courier has evolved significantly, continuously adapting to technological advancements to better serve its customers while maintaining stability in its management and operational approach. The company emphasizes the importance of customer success, fostering long-term relationships with its largest clients and collaborating closely to prepare for future developments in the industry.

BlockJoy

Seed Round in 2021
BlockJoy is a venture-backed Web3 infrastructure company that enables to run their own blockchain nodes on any infrastructure they prefer.

Groups Recover Together

Series C in 2021
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Folx Health

Series A in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

TScan Therapeutics

Series C in 2021
TScan Therapeutics is a biopharmaceutical company dedicated to developing innovative T cell therapies to treat various cancers, including liquid tumors and solid tumors. The company focuses on engineering T cell receptor (TCR) therapies, with specific candidates aimed at addressing hematologic malignancies and preventing relapse after hematopoietic stem cell transplantation. TScan utilizes a specialized platform that identifies shared T cell antigens and minimizes off-target effects, enhancing the safety and effectiveness of its treatments. The company’s pipeline includes both liquid tumor therapies and multiplexed TCR-T candidates for solid tumors. Founded in 2018, TScan Therapeutics is headquartered in Waltham, Massachusetts, and comprises a team of experts committed to expanding treatment options for patients with limited therapeutic alternatives.

Folx Health

Venture Round in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Friday

Seed Round in 2020
Spend more time doing your best work and less time talking about it.

Nebulous

Seed Round in 2020
Nebulous, Inc. is a company focused on developing blockchain hardware and software for the decentralized internet. Founded in 2014 and based in Boston, Massachusetts, it operates Sia, a decentralized cloud storage platform that creates a marketplace for data storage by connecting users in need of file storage with hosts offering underutilized hard drive capacity. Utilizing blockchain technology, Sia enhances security and cost-effectiveness, enabling transactions through smart contracts without the need for intermediaries. In addition to Sia, Nebulous offers Skynet, a decentralized content delivery network and file-sharing platform designed for developers, and SiaStream, which provides affordable storage solutions for media files, facilitating quick streaming. Through these initiatives, Nebulous aims to deliver a robust and economical alternative to traditional cloud storage providers.

Courier

Series A in 2020
Courier provides an API designed for developers to enhance user notification delivery by intelligently routing messages across various existing channels, such as email and messaging platforms. The API takes into account factors like user online status and previous engagement levels to determine the most effective communication method. Over the years, Courier has evolved significantly, continuously adapting to technological advancements to better serve its customers while maintaining stability in its management and operational approach. The company emphasizes the importance of customer success, fostering long-term relationships with its largest clients and collaborating closely to prepare for future developments in the industry.

Nido Biosciences

Venture Round in 2020
Nido Biosciences currently operates in healthcare services. Nido Biosciences specializes in the fields of biotechnology, healthcare, and personal health. It is currently in stealth mode and was founded in 2018.

Folx Health

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Folx Health

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Fractyl Health

Venture Round in 2020
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Kymera Therapeutics

Series C in 2020
Kymera Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts, established in 2015. It specializes in targeted protein degradation, developing innovative small molecule therapeutics that selectively degrade proteins associated with various diseases by utilizing the body's natural protein degradation mechanisms. The company is advancing several therapeutic programs, including the IRAK4 program aimed at treating immunology-inflammation diseases such as hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis. Additionally, it is developing the IRAKIMiD program for MYD88-mutated diffuse large B cell lymphoma and the STAT3 program for hematologic malignancies and solid tumors, as well as autoimmune diseases. Through its proprietary predictive modeling platform, Kymera Therapeutics seeks to accelerate drug discovery and address previously untreatable conditions.

Toast

Series F in 2020
Toast, Inc. is a Boston-based technology company that specializes in developing an all-in-one point-of-sale and restaurant management software tailored for the foodservice and hospitality industries. Founded in 2011, Toast's cloud-based platform provides a comprehensive suite of features, including tableside ordering, online ordering, labor management, and real-time reporting, designed to enhance operational efficiency for restaurants, cafes, bars, and other food establishments. The software facilitates quick menu updates and integrates front-of-house and back-of-house operations, enabling restaurants to streamline their processes and improve guest experiences. With additional offices in Portland, Omaha, and Dublin, Toast aims to support restaurateurs in delivering exceptional service and achieving business success.

Courier

Venture Round in 2020
Courier provides an API designed for developers to enhance user notification delivery by intelligently routing messages across various existing channels, such as email and messaging platforms. The API takes into account factors like user online status and previous engagement levels to determine the most effective communication method. Over the years, Courier has evolved significantly, continuously adapting to technological advancements to better serve its customers while maintaining stability in its management and operational approach. The company emphasizes the importance of customer success, fostering long-term relationships with its largest clients and collaborating closely to prepare for future developments in the industry.

TScan Therapeutics

Series B in 2020
TScan Therapeutics is a biopharmaceutical company dedicated to developing innovative T cell therapies to treat various cancers, including liquid tumors and solid tumors. The company focuses on engineering T cell receptor (TCR) therapies, with specific candidates aimed at addressing hematologic malignancies and preventing relapse after hematopoietic stem cell transplantation. TScan utilizes a specialized platform that identifies shared T cell antigens and minimizes off-target effects, enhancing the safety and effectiveness of its treatments. The company’s pipeline includes both liquid tumor therapies and multiplexed TCR-T candidates for solid tumors. Founded in 2018, TScan Therapeutics is headquartered in Waltham, Massachusetts, and comprises a team of experts committed to expanding treatment options for patients with limited therapeutic alternatives.

TScan Therapeutics

Series B in 2019
TScan Therapeutics is a biopharmaceutical company dedicated to developing innovative T cell therapies to treat various cancers, including liquid tumors and solid tumors. The company focuses on engineering T cell receptor (TCR) therapies, with specific candidates aimed at addressing hematologic malignancies and preventing relapse after hematopoietic stem cell transplantation. TScan utilizes a specialized platform that identifies shared T cell antigens and minimizes off-target effects, enhancing the safety and effectiveness of its treatments. The company’s pipeline includes both liquid tumor therapies and multiplexed TCR-T candidates for solid tumors. Founded in 2018, TScan Therapeutics is headquartered in Waltham, Massachusetts, and comprises a team of experts committed to expanding treatment options for patients with limited therapeutic alternatives.

Nebulous

Seed Round in 2019
Nebulous, Inc. is a company focused on developing blockchain hardware and software for the decentralized internet. Founded in 2014 and based in Boston, Massachusetts, it operates Sia, a decentralized cloud storage platform that creates a marketplace for data storage by connecting users in need of file storage with hosts offering underutilized hard drive capacity. Utilizing blockchain technology, Sia enhances security and cost-effectiveness, enabling transactions through smart contracts without the need for intermediaries. In addition to Sia, Nebulous offers Skynet, a decentralized content delivery network and file-sharing platform designed for developers, and SiaStream, which provides affordable storage solutions for media files, facilitating quick streaming. Through these initiatives, Nebulous aims to deliver a robust and economical alternative to traditional cloud storage providers.

CozyKin

Series A in 2019
CozyKin, inc. provides nanny services for new or expecting parents. It provides childcare services. The company was founded in 2016 and is based in Allston, Massachusetts with an additional office in New York, New York. As of March 12, 2020, CozyKin, inc. operates as a subsidiary of Higher Ground Education Inc.

Toast

Series E in 2019
Toast, Inc. is a Boston-based technology company that specializes in developing an all-in-one point-of-sale and restaurant management software tailored for the foodservice and hospitality industries. Founded in 2011, Toast's cloud-based platform provides a comprehensive suite of features, including tableside ordering, online ordering, labor management, and real-time reporting, designed to enhance operational efficiency for restaurants, cafes, bars, and other food establishments. The software facilitates quick menu updates and integrates front-of-house and back-of-house operations, enabling restaurants to streamline their processes and improve guest experiences. With additional offices in Portland, Omaha, and Dublin, Toast aims to support restaurateurs in delivering exceptional service and achieving business success.

Affirmed Networks

Venture Round in 2019
Affirmed Networks, Inc. specializes in providing mobile content cloud solutions globally, focusing on virtualization and network functions. Founded in 2010 and based in Acton, Massachusetts, the company offers a range of services including the Affirmed Service Automation Platform, which helps mobile operators streamline service introduction and reduce operational costs. Their solutions encompass a cloud-based virtual network for Internet of Things services, critical data communications for telecommunications, and virtualized Evolved Packet Core solutions for live traffic management. Additionally, Affirmed Networks has developed UnityCloud 5G core, a cloud-native platform designed to facilitate the deployment of 5G networks for mobile operators. The company's innovative approach aims to enhance intelligence and efficiency in mobile data networks.

Bevi

Series C in 2019
Bevi aims to eliminate waste from the production, shipping, and disposing of bottled beverages. We envision a future where a smarter platform (powered by the municipal water supply) transforms how beverages are delivered. It is an ambitious goal, but we are on it!

Kymera Therapeutics

Series B in 2018
Kymera Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts, established in 2015. It specializes in targeted protein degradation, developing innovative small molecule therapeutics that selectively degrade proteins associated with various diseases by utilizing the body's natural protein degradation mechanisms. The company is advancing several therapeutic programs, including the IRAK4 program aimed at treating immunology-inflammation diseases such as hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis. Additionally, it is developing the IRAKIMiD program for MYD88-mutated diffuse large B cell lymphoma and the STAT3 program for hematologic malignancies and solid tumors, as well as autoimmune diseases. Through its proprietary predictive modeling platform, Kymera Therapeutics seeks to accelerate drug discovery and address previously untreatable conditions.

Renoviso

Series B in 2018
Renoviso, Inc., based in North Andover, Massachusetts, specializes in home renovation services, particularly in window and door replacement, as well as hardwood flooring. Established in 2014, the company leverages technology to enhance the renovation experience for homeowners, offering customized online pricing from reputable brands in the home improvement sector. Renoviso manages the entire renovation process, from professional measurement to installation, ensuring transparency and a high level of customer satisfaction. Its innovative approach has garnered positive reviews from homeowners across eastern New England, highlighting Renoviso's commitment to quality and affordability in home renovation projects.

Decibel Therapeutics

Series C in 2018
Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing therapies aimed at protecting, repairing, and restoring hearing. The company focuses on a range of hearing disorders, including those related to cancer treatments, cystic fibrosis, noise exposure, age-related and genetic hearing loss, as well as tinnitus. It utilizes advanced techniques such as single-cell genomics, bioinformatics, and precision gene therapy technologies to enhance its understanding of inner ear pathology and to develop effective treatments. Decibel Therapeutics also offers expertise in drug delivery to the inner ear, imaging, and pharmacokinetic modeling, contributing to innovative therapeutic approaches for patients experiencing various forms of hearing loss. Founded in 2013 and based in Boston, Massachusetts, Decibel Therapeutics was previously known as Hearing, Inc. before rebranding in 2014.

CozyKin

Seed Round in 2017
CozyKin, inc. provides nanny services for new or expecting parents. It provides childcare services. The company was founded in 2016 and is based in Allston, Massachusetts with an additional office in New York, New York. As of March 12, 2020, CozyKin, inc. operates as a subsidiary of Higher Ground Education Inc.

Fractyl Health

Series D in 2017
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Edmit

Seed Round in 2017
Edmit was founded by innovative university leaders passionate about student success. We believe students should feel empowered in the college admissions and financial aid process, and that colleges should have more effective ways to engage directly with students on pricing in order to effectively bring great students to their institution.
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic conditions. Its proprietary technological approach enables the design, formulation, and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. It was founded in 2011 and headquartered in Newton, Massachusetts.

Groups Recover Together

Venture Round in 2017
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Toast

Series C in 2017
Toast, Inc. is a Boston-based technology company that specializes in developing an all-in-one point-of-sale and restaurant management software tailored for the foodservice and hospitality industries. Founded in 2011, Toast's cloud-based platform provides a comprehensive suite of features, including tableside ordering, online ordering, labor management, and real-time reporting, designed to enhance operational efficiency for restaurants, cafes, bars, and other food establishments. The software facilitates quick menu updates and integrates front-of-house and back-of-house operations, enabling restaurants to streamline their processes and improve guest experiences. With additional offices in Portland, Omaha, and Dublin, Toast aims to support restaurateurs in delivering exceptional service and achieving business success.

Toast

Series C in 2017
Toast, Inc. is a Boston-based technology company that specializes in developing an all-in-one point-of-sale and restaurant management software tailored for the foodservice and hospitality industries. Founded in 2011, Toast's cloud-based platform provides a comprehensive suite of features, including tableside ordering, online ordering, labor management, and real-time reporting, designed to enhance operational efficiency for restaurants, cafes, bars, and other food establishments. The software facilitates quick menu updates and integrates front-of-house and back-of-house operations, enabling restaurants to streamline their processes and improve guest experiences. With additional offices in Portland, Omaha, and Dublin, Toast aims to support restaurateurs in delivering exceptional service and achieving business success.

Clear Ballot Group, Inc.

Venture Round in 2017
Clear Ballot Group, Inc. develops election software and hardware products. The company offers ClearVote, a vote visualization system for election officials. It also provides modular voting systems, and software tools and hardware. The company serves counties and municipalities in the United States. Clear Ballot Group, Inc. was founded in 2009 and is based in Boston, Massachusetts.

Fam

Convertible Note in 2017
Fam's mission is to build products that revolutionize the way teens and millennials communicate. They believe in a calculated combination of live group video and group chat messaging to execute this. It is the world’s first group video chat app for iMessage, with over 7 million users. Their app instantly connects with the family and friends closest to its user through group video calling, right from their iPhone, and Android text message app.

Quantopian

Series C in 2016
Quantopian, Inc. operates an online platform for developing and testing quantitative trading algorithms. Its platform provides tools and infrastructure for users to learn about quantitative finance by joining the community discussions and exploring algorithms that other members have shared; create and backtest algorithms; review results and risk metrics; and trade their algorithmic strategies. Quantopian, Inc. was incorporated in 2011 and is based in Boston, Massachusetts.

Renoviso

Series A in 2016
Renoviso, Inc., based in North Andover, Massachusetts, specializes in home renovation services, particularly in window and door replacement, as well as hardwood flooring. Established in 2014, the company leverages technology to enhance the renovation experience for homeowners, offering customized online pricing from reputable brands in the home improvement sector. Renoviso manages the entire renovation process, from professional measurement to installation, ensuring transparency and a high level of customer satisfaction. Its innovative approach has garnered positive reviews from homeowners across eastern New England, highlighting Renoviso's commitment to quality and affordability in home renovation projects.

Docent Health

Series A in 2016
Docent Health's mission is to help health systems build and retain lasting patient relationships. We are combining best practices from other industries to help health systems deliver the vision of customer-centric care by combining cutting edge consumer technology, retail based strategic marketing, and hospitality inspired service excellence with deep provider experience to increase customer lifetime value and grow market share.

Alcresta

Series C in 2016
Alcresta Therapeutics, Inc. develops and commercializes enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's primary offering, RELiZORB, is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase for adults on enteral tube feeding who struggle to break down and absorb fats. Established in 2011 and based in Warren, New Jersey, Alcresta focuses on innovative, point-of-care nutritional products that enhance nutrition and manage health conditions for various populations, including infants, aging adults, and individuals with acute or chronic diseases. The company leverages its expertise in both adult and pediatric nutrition, along with protein manufacturing and regulatory knowledge, to address the unmet nutritional needs of those with compromised health.

SmashFly Technologies

Series B in 2016
SmashFly Technologies’s award-winning Total Recruitment Marketing Platform enables talent acquisition teams to attract, engage, nurture and convert candidates into qualified applicants using a centralized management system that automates and measures recruiting strategies and programs. Customers use SmashFly to unite their previously disconnected recruiting tools into an integrated software platform for Job Distribution, Candidate Relationship Management (CRM), Talent Networks, mobile-responsive and SEO-optimized Career Sites, Employee Referrals, Social Recruiting and Recruiting Analytics. Used to target pre-applicants in the front-end of the talent acquisition process, SmashFly integrates with any applicant tracking system (ATS) to provide unparalleled, real-time analytics on the sources that produce the best hires for the organization.

Docent Health

Seed Round in 2016
Docent Health's mission is to help health systems build and retain lasting patient relationships. We are combining best practices from other industries to help health systems deliver the vision of customer-centric care by combining cutting edge consumer technology, retail based strategic marketing, and hospitality inspired service excellence with deep provider experience to increase customer lifetime value and grow market share.

Toast

Series B in 2016
Toast, Inc. is a Boston-based technology company that specializes in developing an all-in-one point-of-sale and restaurant management software tailored for the foodservice and hospitality industries. Founded in 2011, Toast's cloud-based platform provides a comprehensive suite of features, including tableside ordering, online ordering, labor management, and real-time reporting, designed to enhance operational efficiency for restaurants, cafes, bars, and other food establishments. The software facilitates quick menu updates and integrates front-of-house and back-of-house operations, enabling restaurants to streamline their processes and improve guest experiences. With additional offices in Portland, Omaha, and Dublin, Toast aims to support restaurateurs in delivering exceptional service and achieving business success.

Fractyl Health

Series C in 2015
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

CyPhy Works

Series B in 2015
CyPhy Works, now known as Aria Insights, specializes in the development of intelligent aerial robots designed to operate in challenging and hazardous environments. By integrating advanced technology, these robots collect and analyze data, providing actionable insights to decision-makers. This approach not only enhances operational efficiency but also prioritizes safety by minimizing human exposure to risky situations. Through their innovative solutions, Aria Insights aims to transform data collection and analysis in various sectors, ensuring that critical information is delivered effectively and securely.

Apperian

Series C in 2015
Apperian is a developer of cloud-based mobile application management services. It provides mobile app security and dynamic policy controls via app wrapping, creating individual app containers for deployments where mobile device management approaches are not possible or desired, such as BYOD, contract workers, dealer networks, and other unmanaged devices. It develops enterprise-class mobile application management (MAM) and security platform for the delivery of application users across an organization. Apperian was founded in 2009 and is headquartered in Boston, Massachusetts.

HelloShopper

Seed Round in 2015
HelloShopper (formerly known as Scratch) is an e-commerce service that helps consumers give great gifts (to someone else or to treat themselves!). Unless you know exactly what you’re looking for, finding a great product online can be a challenge. We believe you shouldn’t have to settle for whatever shows up on the first page of search results, so we’re building a service that makes giving great gifts, from unique brands, as easy as sending a text message. Featured as Apple’s top ‘Best New App’ in February 2016, our chat-based mobile and web app connects customers with a network of gift shoppers, on-demand, from any device. We supercharge our shoppers with the extensive data we’ve accumulated through thousands of customer interactions, which helps us send on-target recommendations quickly, every time. Customers simply tell us who they are shopping for and answer a couple questions about their interests. Within a few hours, our shoppers send them great recommendations from unique brands. It’s completely free and customers can buy right from us with confidence, since every purchase is backed by our best price guarantee. Founded in August 2014, we've raised $3.6M so far from top-tier VCs Bessemer Venture Partners, NextView Ventures, Red Swan and Aspiration Growth. Our team includes alums from TripAdvisor, Microsoft, Wayfair, RunKeeper, CustomMade and Karmaloop.

N Toggle

Series A in 2015
nToggle delivers heightened efficiency and transparency for buyers and sellers amidst the rapid rise of programmatic advertising. nToggle's proprietary algorithm-driven software platform helps supply and demand partners manage the ever expanding bid stream. nToggle's big data platform “toggles” real time bidding requests across all digital media utilizing the latest analytical and machine learning techniques to optimally match supply and demand.

Allena Pharmaceuticals

Series B in 2014
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic conditions. Its proprietary technological approach enables the design, formulation, and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. It was founded in 2011 and headquartered in Newton, Massachusetts.

Quantopian

Series B in 2014
Quantopian, Inc. operates an online platform for developing and testing quantitative trading algorithms. Its platform provides tools and infrastructure for users to learn about quantitative finance by joining the community discussions and exploring algorithms that other members have shared; create and backtest algorithms; review results and risk metrics; and trade their algorithmic strategies. Quantopian, Inc. was incorporated in 2011 and is based in Boston, Massachusetts.

Fractyl Health

Series B in 2014
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

JetPatch

Series B in 2014
JetPatch is a centralized patch management platform focusing on end-to-end enterprise patch management & vulnerability remediation. The platform ensures your systems are always secure, up-to-date and running smoothly through a centralized and automated patch management system. It also leverages your existing patch managers. JetPatch Agent Manager saves IT and DevOps professionals countless hours of tedious workaround deploying, maintaining and troubleshooting server tool agents. The platform uses machine learning technology to optimize patch rollouts, resulting in more secure systems and shorter downtimes. JetPatch was founded in 2017 and is headquartered in Newton Center, Massachusetts.

Ellevation

Venture Round in 2014
Ellevation, LLC is a Boston-based company that develops a web-based software platform aimed at supporting English learners (EL) and the educators who serve them. The platform organizes EL student data, facilitates critical monitoring processes, and aids in instructional planning for multilingual students. Ellevation offers research-based instructional practices and activities that assist classroom teachers in effectively planning lessons to help ELs acquire language skills and master grade-level content. Additionally, the company provides Ellevation Math, specifically designed to help ELs engage with grade-level math concepts. Serving various public school districts, including EL coordinators, specialists, and teachers, Ellevation aims to enhance educational outcomes for English learners across the United States. Founded in 2006, the company was previously known as ESL Innovations, Inc. and rebranded to Ellevation, LLC in 2011.

CloudLock

Series C in 2014
CloudLock LLC develops a cloud cybersecurity platform that enables organizations to securely utilize cloud applications. Founded in 2007 and headquartered in Waltham, Massachusetts, the company delivers security solutions for various cloud services, including infrastructure, platform, and identity management. Its offerings include codeless security for custom applications, incident management, user behavior monitoring, and encryption management. CloudLock serves a wide range of industries, such as manufacturing, technology, financial services, healthcare, and education, providing actionable cybersecurity intelligence across their cloud infrastructures. As of August 2016, the company operates as a subsidiary of Cisco Systems, expanding its influence and capabilities in the cybersecurity market.

Infinio

Series B in 2013
Infinio addresses the most expensive bottleneck in virtual environments: storage performance. Data center administrators buy more storage hardware when what they really want is better storage performance. Infinio offers a software-only solution instead. Infinio has strong financial backing from tier-one venture capitalists including Highland Capital Partners, Bessemer Venture Partners, Lightspeed Venture Partners and Osage University Partners.

Anaqua

Private Equity Round in 2013
Anaqua offers intellectual property (IP) management software and services tailored for various users, including large IP owners, smaller teams, and law firms. Its product suite includes Anaqua Enterprise for larger organizations, Anaqua Express for smaller teams, ANAQUA Element for cloud-based IP management, and ANAQUA Essential for legal practices. The company's solutions address all aspects of the IP lifecycle, covering inventions, patents, trademarks, and more. Anaqua's platform is entirely web-based, featuring automated workflows, integrated document and email management, and advanced query and reporting capabilities. By enhancing business productivity and improving IP visibility, Anaqua supports all participants in the IP management process.

Ellevation

Series A in 2013
Ellevation, LLC is a Boston-based company that develops a web-based software platform aimed at supporting English learners (EL) and the educators who serve them. The platform organizes EL student data, facilitates critical monitoring processes, and aids in instructional planning for multilingual students. Ellevation offers research-based instructional practices and activities that assist classroom teachers in effectively planning lessons to help ELs acquire language skills and master grade-level content. Additionally, the company provides Ellevation Math, specifically designed to help ELs engage with grade-level math concepts. Serving various public school districts, including EL coordinators, specialists, and teachers, Ellevation aims to enhance educational outcomes for English learners across the United States. Founded in 2006, the company was previously known as ESL Innovations, Inc. and rebranded to Ellevation, LLC in 2011.

Alcresta

Series B in 2013
Alcresta Therapeutics, Inc. develops and commercializes enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's primary offering, RELiZORB, is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase for adults on enteral tube feeding who struggle to break down and absorb fats. Established in 2011 and based in Warren, New Jersey, Alcresta focuses on innovative, point-of-care nutritional products that enhance nutrition and manage health conditions for various populations, including infants, aging adults, and individuals with acute or chronic diseases. The company leverages its expertise in both adult and pediatric nutrition, along with protein manufacturing and regulatory knowledge, to address the unmet nutritional needs of those with compromised health.

Affirmed Networks

Series C in 2013
Affirmed Networks, Inc. specializes in providing mobile content cloud solutions globally, focusing on virtualization and network functions. Founded in 2010 and based in Acton, Massachusetts, the company offers a range of services including the Affirmed Service Automation Platform, which helps mobile operators streamline service introduction and reduce operational costs. Their solutions encompass a cloud-based virtual network for Internet of Things services, critical data communications for telecommunications, and virtualized Evolved Packet Core solutions for live traffic management. Additionally, Affirmed Networks has developed UnityCloud 5G core, a cloud-native platform designed to facilitate the deployment of 5G networks for mobile operators. The company's innovative approach aims to enhance intelligence and efficiency in mobile data networks.

Infinio

Series A in 2013
Infinio addresses the most expensive bottleneck in virtual environments: storage performance. Data center administrators buy more storage hardware when what they really want is better storage performance. Infinio offers a software-only solution instead. Infinio has strong financial backing from tier-one venture capitalists including Highland Capital Partners, Bessemer Venture Partners, Lightspeed Venture Partners and Osage University Partners.

JetPatch

Series A in 2013
JetPatch is a centralized patch management platform focusing on end-to-end enterprise patch management & vulnerability remediation. The platform ensures your systems are always secure, up-to-date and running smoothly through a centralized and automated patch management system. It also leverages your existing patch managers. JetPatch Agent Manager saves IT and DevOps professionals countless hours of tedious workaround deploying, maintaining and troubleshooting server tool agents. The platform uses machine learning technology to optimize patch rollouts, resulting in more secure systems and shorter downtimes. JetPatch was founded in 2017 and is headquartered in Newton Center, Massachusetts.

Cerulean Pharma

Private Equity Round in 2012
Cerulean Pharma Inc. is a privately-held biopharmaceutical company dedicated to developing innovative therapeutics utilizing nanotechnology, specifically targeting oncology, cardiovascular, autoimmune, and inflammatory diseases. The company has established a highly skilled management team and advisory boards, drawing expertise from renowned organizations and institutions, including significant contributions from leading figures in the pharmaceutical industry and prestigious academic centers. Cerulean is recognized for its leadership in nanoparticle-drug conjugates, which represent a promising approach to enhancing the efficacy and safety of treatments. Through its commitment to scientific advancement, Cerulean Pharma aims to address unmet medical needs and improve patient outcomes in various disease areas.

WireOver

Seed Round in 2012
WireOver is a desktop application that leverages peer-to-peer technology for sending files privately. It's free and unlimited, solving an unmet need for sending large files easily. Pro accounts get incredibly strong security, with end-to-end encryption.

Alcresta

Series A in 2012
Alcresta Therapeutics, Inc. develops and commercializes enzyme-based products aimed at treating gastrointestinal disorders and rare diseases. The company's primary offering, RELiZORB, is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase for adults on enteral tube feeding who struggle to break down and absorb fats. Established in 2011 and based in Warren, New Jersey, Alcresta focuses on innovative, point-of-care nutritional products that enhance nutrition and manage health conditions for various populations, including infants, aging adults, and individuals with acute or chronic diseases. The company leverages its expertise in both adult and pediatric nutrition, along with protein manufacturing and regulatory knowledge, to address the unmet nutritional needs of those with compromised health.

Apperian

Series B in 2012
Apperian is a developer of cloud-based mobile application management services. It provides mobile app security and dynamic policy controls via app wrapping, creating individual app containers for deployments where mobile device management approaches are not possible or desired, such as BYOD, contract workers, dealer networks, and other unmanaged devices. It develops enterprise-class mobile application management (MAM) and security platform for the delivery of application users across an organization. Apperian was founded in 2009 and is headquartered in Boston, Massachusetts.

Cerulean Pharma

Series D in 2011
Cerulean Pharma Inc. is a privately-held biopharmaceutical company dedicated to developing innovative therapeutics utilizing nanotechnology, specifically targeting oncology, cardiovascular, autoimmune, and inflammatory diseases. The company has established a highly skilled management team and advisory boards, drawing expertise from renowned organizations and institutions, including significant contributions from leading figures in the pharmaceutical industry and prestigious academic centers. Cerulean is recognized for its leadership in nanoparticle-drug conjugates, which represent a promising approach to enhancing the efficacy and safety of treatments. Through its commitment to scientific advancement, Cerulean Pharma aims to address unmet medical needs and improve patient outcomes in various disease areas.

Allena Pharmaceuticals

Series A in 2011
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic conditions. Its proprietary technological approach enables the design, formulation, and delivery of non-absorbed and stable enzymes orally and in sufficient doses for activity in the GI tract. It was founded in 2011 and headquartered in Newton, Massachusetts.

Verastem

Series C in 2011
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Hadapt

Series A in 2011
Hadapt is a developer of an adaptive analytical platform designed to facilitate complex analytics on both structured and unstructured data. This platform operates in private and public cloud environments, providing a cloud-optimized system for data analysis. Hadapt's Adaptive Query Execution solution enhances performance by dynamically load balancing queries in virtualized settings, enabling analytical workloads to be efficiently distributed between relational database engines and Hadoop, an open-source parallel data processing framework. Additionally, the platform supports SQL, making it versatile for various analytical tasks.

Proteon Therapeutics

Series C in 2011
Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

Verastem

Series B in 2011
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Apperian

Venture Round in 2011
Apperian is a developer of cloud-based mobile application management services. It provides mobile app security and dynamic policy controls via app wrapping, creating individual app containers for deployments where mobile device management approaches are not possible or desired, such as BYOD, contract workers, dealer networks, and other unmanaged devices. It develops enterprise-class mobile application management (MAM) and security platform for the delivery of application users across an organization. Apperian was founded in 2009 and is headquartered in Boston, Massachusetts.

Verastem

Series A in 2010
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Cerulean Pharma

Series C in 2010
Cerulean Pharma Inc. is a privately-held biopharmaceutical company dedicated to developing innovative therapeutics utilizing nanotechnology, specifically targeting oncology, cardiovascular, autoimmune, and inflammatory diseases. The company has established a highly skilled management team and advisory boards, drawing expertise from renowned organizations and institutions, including significant contributions from leading figures in the pharmaceutical industry and prestigious academic centers. Cerulean is recognized for its leadership in nanoparticle-drug conjugates, which represent a promising approach to enhancing the efficacy and safety of treatments. Through its commitment to scientific advancement, Cerulean Pharma aims to address unmet medical needs and improve patient outcomes in various disease areas.

On-Q-ity

Series A in 2009
On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. There platform will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream.

Cerulean Pharma

Series B in 2009
Cerulean Pharma Inc. is a privately-held biopharmaceutical company dedicated to developing innovative therapeutics utilizing nanotechnology, specifically targeting oncology, cardiovascular, autoimmune, and inflammatory diseases. The company has established a highly skilled management team and advisory boards, drawing expertise from renowned organizations and institutions, including significant contributions from leading figures in the pharmaceutical industry and prestigious academic centers. Cerulean is recognized for its leadership in nanoparticle-drug conjugates, which represent a promising approach to enhancing the efficacy and safety of treatments. Through its commitment to scientific advancement, Cerulean Pharma aims to address unmet medical needs and improve patient outcomes in various disease areas.

Proteon Therapeutics

Series B in 2009
Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

StreamBase Systems

Series D in 2009
StreamBase Systems provides software for rapidly building systems that analyze and act on real-time streaming data for instantaneous decision-making. StreamBase's Event Processing Platform combines a rapid application development environment, a low-latency high-throughput event server, and the broadest connectivity to real-time and historical data. Investment banks, hedge funds, and government agencies use StreamBase to power applications that increase revenue, lower costs, and reduce risk. The company is headquartered in Waltham, Massachusetts

Alnara Pharmaceuticals

Series A in 2008
Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.

Stromedix

Series B in 2008
Stromedix is a biomedical company that specializes in developing drugs for chronic conditions, with an initial focus on fibrosis and organ failure. The company aims to leverage its expertise to expand its therapeutic pipeline into related areas, including acute organ failure and cancer. By targeting these significant health challenges, Stromedix seeks to contribute to advancements in treatment options and improve patient outcomes.

Storwize

Series C in 2008
Storwize, Inc. is the only provider of real-time data compression solutions that dramatically boost storage space on network storage environments. Storwize appliances are installed between the organization's storage arrays and their network. Designed to work with any storage array it is connected to, the Storwize appliance typically provides organizations with 2-5X additional capacity with associated savings in capital, operational, maintenance and management resources. Storwize solutions have been shipped to customer sites worldwide and successfully tested for interoperability with leading storage vendors such as EMC and NetApp. Storwize has won several coveted industry honors from analyst firms and leading IT publications, and added multiple new customers in different vertical markets worldwide. Increase the effective capacity of existing NAS infrastructure up to 15x with Storwize’s STN-6000p capacity optimization platform featuring real-time lossless data compression. Based upon a powerful multi-core hardware platform, the STN-6000p appliance is deployed between the network, switch and storage providing average data compression of > 65% across multiple applications and more than 90% on business critical applications without performance degradation, enabling it to be deployed in even the most data intensive enterprise environments. The appliance does not require workflow changes, software agents or server drivers and can be deployed seamlessly without any configuration changes to existing environments.

Cerulean Pharma

Series B in 2008
Cerulean Pharma Inc. is a privately-held biopharmaceutical company dedicated to developing innovative therapeutics utilizing nanotechnology, specifically targeting oncology, cardiovascular, autoimmune, and inflammatory diseases. The company has established a highly skilled management team and advisory boards, drawing expertise from renowned organizations and institutions, including significant contributions from leading figures in the pharmaceutical industry and prestigious academic centers. Cerulean is recognized for its leadership in nanoparticle-drug conjugates, which represent a promising approach to enhancing the efficacy and safety of treatments. Through its commitment to scientific advancement, Cerulean Pharma aims to address unmet medical needs and improve patient outcomes in various disease areas.

Acceleron Pharma

Series C in 2007
Acceleron Pharma Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics for serious and rare diseases. The company is known for luspatercept-aamt, marketed as REBLOZYL, which treats anemia in adult patients with beta-thalassemia. Additionally, it is developing luspatercept-aamt for myelodysplastic syndromes and myelofibrosis, while Sotatercept targets pulmonary arterial hypertension. Acceleron is also advancing ACE-083, a neuromuscular candidate in Phase II trials aimed at Charcot-Marie-Tooth disease. The company's research focuses on biotherapeutics that influence the growth of bone, muscle, fat, and blood vessels to address conditions such as cancer-related bone and muscle loss, as well as various metabolic disorders. Founded in 2003 and based in Cambridge, Massachusetts, Acceleron has established collaborations with Celgene Corporation and Fulcrum Therapeutics to enhance its therapeutic offerings in the pulmonary disease space.

Consumer Powerline

Series A in 2007
ConsumerPowerline’s products and services help their customers pay the least for energy, get the most for energy they buy, and earn the most for what they can reduce. They are unique in how they approach the market - they use deregulated market opportunities to first create new revenue for their customers. This new income and the accompanying new information helps their customers achieve a lot more, a lot sooner with them. The ConsumerPowerline team leverages their unique combination of skills and experience to uncover revenues and savings other firms overlook. ConsumerPowerline offers Strategic Energy Asset Management (SEAM) including comprehensive energy audits and analyses; identification, design, and project management of demand response opportunities; generator uploading, load switching and controls; efficiency consultations; and performance-based contracting. ConsumerPowerline also offers demand response management. They bring clients a means of financing improved energy management by first generating revenues through demand response – which requires no up-front investment and a limited time commitment. In the summer of 2005, ConsumerPowerline helped their New York City customers secure an estimated $6 million by selling their excess capacity back into the energy markets. ConsumerPowerline operates on a national basis with specific emphasis on the New York, New England, and California markets.

Proteon Therapeutics

Series A in 2007
Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases. The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics’ first drug candidate (PRT-201) is in development for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD).

StreamBase Systems

Series C in 2007
StreamBase Systems provides software for rapidly building systems that analyze and act on real-time streaming data for instantaneous decision-making. StreamBase's Event Processing Platform combines a rapid application development environment, a low-latency high-throughput event server, and the broadest connectivity to real-time and historical data. Investment banks, hedge funds, and government agencies use StreamBase to power applications that increase revenue, lower costs, and reduce risk. The company is headquartered in Waltham, Massachusetts

WAY Systems

Series C in 2007
WAY Systems, Inc. designs, develops, and sells mobile wireless point-of-sale (POS) solutions for mobile merchants in the United States and internationally. It provides mobile POS devices and printers, as well as various accessory items, including antenna kits, printer papers, car chargers, cigarette lighter adapters, holsters, printer batteries, and AC chargers through its store. The company also offers end-to-end infrastructure solutions, including hardware, software, and messaging elements for mobile application development, deployment, and maintenance. In addition, it supports GMS and GPRS for geographic coverage and security, as well as provides end-to-end payment and transaction processing services. The company was founded in 2002 and is based in Woburn, Massachusetts.

Vertica

Series B in 2007
Vertica Systems, Inc. specializes in developing advanced data management solutions, particularly through its flagship product, the Vertica Analytic Database. This platform is designed for high-performance data analysis at scale, enabling users to conduct near-real-time and ad hoc queries across large datasets. Vertica's offerings include a cloud-based version of its analytic database and a hardware/software appliance, catering to diverse applications such as data warehousing, fraud detection, and business intelligence. The company also supports early-stage companies through its Vertica Startup Accelerator program, which provides access to its analytics platform and resources to help entrepreneurs develop innovative solutions for big data challenges. Founded in 2005 and headquartered in Billerica, Massachusetts, Vertica has established strategic partnerships with various technology firms to enhance its ecosystem and drive innovation in data analytics.

Revivio

Series C in 2006
Revivio, Inc. specializes in continuous data protection solutions tailored for enterprises. Founded in 2001 and based in Lexington, Massachusetts, the company offers a range of products including the Continuous Protection System, which allows organizations to restore data instantly and recover business applications, thereby eliminating traditional backup windows. The Continuous Protection System 1200i is designed for the recovery of mission-critical applications, providing rapid data retrieval in cases of loss, corruption, or disaster. Additionally, Revivio offers the Continuous Protection System Replication Module, which supports stringent disaster recovery requirements by extending continuous data protection benefits to remote sites. In November 2006, Revivio was acquired by Symantec Corp.

Mangrove Systems

Series C in 2006
Mangrove Systems provides multi-service access and aggregation platforms for 3G wireless and wireline networks. It offers Piranha that combine the packet and circuit-switched technology to deliver Ethernet, ATM, TDM private line and IP/PPP services over any transport infrastructure. It offers fixed line, mobile, and cable/multi service operators solutions. The company was founded in 2002 and is headquartered in Wallingford, Connecticut.

Sirtris Pharmaceuticals

Series C in 2006
Sirtris Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of proprietary, orally available small molecule drugs aimed at treating diseases related to aging. The company's research primarily focuses on metabolic disorders, including Type 2 Diabetes. By leveraging innovative approaches in drug development, Sirtris seeks to address the growing healthcare challenges associated with age-related diseases.

SiteAdvisor

Series A in 2006
SiteAdvisor. The Boston, Mass. based company maintains a database of Web sites that it tests for spyware, adware, spam, browser attacks, and online scams.

Vertica

Series A in 2006
Vertica Systems, Inc. specializes in developing advanced data management solutions, particularly through its flagship product, the Vertica Analytic Database. This platform is designed for high-performance data analysis at scale, enabling users to conduct near-real-time and ad hoc queries across large datasets. Vertica's offerings include a cloud-based version of its analytic database and a hardware/software appliance, catering to diverse applications such as data warehousing, fraud detection, and business intelligence. The company also supports early-stage companies through its Vertica Startup Accelerator program, which provides access to its analytics platform and resources to help entrepreneurs develop innovative solutions for big data challenges. Founded in 2005 and headquartered in Billerica, Massachusetts, Vertica has established strategic partnerships with various technology firms to enhance its ecosystem and drive innovation in data analytics.

WAY Systems

Series C in 2005
WAY Systems, Inc. designs, develops, and sells mobile wireless point-of-sale (POS) solutions for mobile merchants in the United States and internationally. It provides mobile POS devices and printers, as well as various accessory items, including antenna kits, printer papers, car chargers, cigarette lighter adapters, holsters, printer batteries, and AC chargers through its store. The company also offers end-to-end infrastructure solutions, including hardware, software, and messaging elements for mobile application development, deployment, and maintenance. In addition, it supports GMS and GPRS for geographic coverage and security, as well as provides end-to-end payment and transaction processing services. The company was founded in 2002 and is based in Woburn, Massachusetts.

Vertica

Venture Round in 2005
Vertica Systems, Inc. specializes in developing advanced data management solutions, particularly through its flagship product, the Vertica Analytic Database. This platform is designed for high-performance data analysis at scale, enabling users to conduct near-real-time and ad hoc queries across large datasets. Vertica's offerings include a cloud-based version of its analytic database and a hardware/software appliance, catering to diverse applications such as data warehousing, fraud detection, and business intelligence. The company also supports early-stage companies through its Vertica Startup Accelerator program, which provides access to its analytics platform and resources to help entrepreneurs develop innovative solutions for big data challenges. Founded in 2005 and headquartered in Billerica, Massachusetts, Vertica has established strategic partnerships with various technology firms to enhance its ecosystem and drive innovation in data analytics.

StreamBase Systems

Series B in 2005
StreamBase Systems provides software for rapidly building systems that analyze and act on real-time streaming data for instantaneous decision-making. StreamBase's Event Processing Platform combines a rapid application development environment, a low-latency high-throughput event server, and the broadest connectivity to real-time and historical data. Investment banks, hedge funds, and government agencies use StreamBase to power applications that increase revenue, lower costs, and reduce risk. The company is headquartered in Waltham, Massachusetts

Revivio

Series C in 2005
Revivio, Inc. specializes in continuous data protection solutions tailored for enterprises. Founded in 2001 and based in Lexington, Massachusetts, the company offers a range of products including the Continuous Protection System, which allows organizations to restore data instantly and recover business applications, thereby eliminating traditional backup windows. The Continuous Protection System 1200i is designed for the recovery of mission-critical applications, providing rapid data retrieval in cases of loss, corruption, or disaster. Additionally, Revivio offers the Continuous Protection System Replication Module, which supports stringent disaster recovery requirements by extending continuous data protection benefits to remote sites. In November 2006, Revivio was acquired by Symantec Corp.

Endeca

Series C in 2004
Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.

BuyerZone

Venture Round in 2004
BuyerZone.com, LLC operates as an online marketplace that connects buyers and sellers of various business products and services. Established in 1992 and headquartered in Waltham, Massachusetts, the company provides a free quote request service that facilitates access to a wide range of categories, including automotive, healthcare, office equipment, and software, among others. BuyerZone caters primarily to small businesses, companies, and public sector organizations, enabling millions of active buyers to seek purchasing guidance across over 125 product and service categories. The company is a division of TechMedia Network.

StreamBase Systems

Series A in 2003
StreamBase Systems provides software for rapidly building systems that analyze and act on real-time streaming data for instantaneous decision-making. StreamBase's Event Processing Platform combines a rapid application development environment, a low-latency high-throughput event server, and the broadest connectivity to real-time and historical data. Investment banks, hedge funds, and government agencies use StreamBase to power applications that increase revenue, lower costs, and reduce risk. The company is headquartered in Waltham, Massachusetts